the 32nd nuf congress · o1-04 can do-it-yourself (diy) qmean identify the obstructed male patient?...

THE 32ND

NUF CONGRESSJUNE 5 – 8 2019 | REYKJAVIK, ICELAND

#NUF2019

Scan

dina

vian

Association of Uro logy

Scan

dina

vian


Scan

dina

vian


Harpa Concert

HallIðnó Gamla

Bíó

THE 32ND

NUF CONGRESSJUNE 5 – 8 2019 | REYKJAVIK, ICELAND

EXHIBITION

Conference Secretary:Birna Björg Berndsen,[email protected], tel: +354 8638536Þórunn Dögg Harðardóttir, [email protected], tel: +354 899 5878

COMMITTEES

Organizing committeeSigurdur Gudjonsson, urologist - [email protected]íkur Orri Gudmundsson, urologist - [email protected] Hilmarsson, urologist - [email protected] Gudmundsottir, urology nurse - [email protected] Eva Sigurdardottir, urology nurse - [email protected]ður Jonsdottir, surgical nurse - [email protected]

7

7:45 - 8:00 Coffee / Tea

SILFURBERG B KALDALÓN RÍMA A08:00 - 08.15

08:15 -09:30

OpeningSigurður Guðjónsson (ISL)Christian Beisland (NOR)

Joint session - Prostate cancer screening / early detectionModerator: Jón Örn Friðriksson (ISL)ScreeningPer-Anders Abrahamson (SWE)The Role of MRICaroline Moore (GBR) First results from Patient-overview Prostate Cancer- decision aid and clinical cancer registerPär Stattin (SWE) Overview of prophylactic antibiotics for prostate biopsiesKarl-Johan Lundström (SWE)

09:30 - 10:00 - Coffee break & Posters P01 - P1610:00 - 11:30 Functional urology

Topic: UTI, cystitis (parasites, eosinophilia, IC….) Cases will be included in each lectureWelcome/introduction Moderator: Karl Erlingur Oddason (ISL)

Profylaxis and resistancy Agnar Bjarnason (ISL)

Recurrent and refractory infections Bryndís Sigurðardóttir (ISL)

Neurological bladder dysfunction and UTI Lotta Koskela (SWE)

Renal cancerModerators: Pernilla Sundquist (SWE) & Eiríkur Orri Guðmundsson (ISL)Treatment strategy Börje Ljungberg (SWE)Surveillance Pernilla Sundquist (SWE)Surgical techniques Frode S. Nilsen (NOR)Lymph node dissection Nessn Azawi (DAN)Tumor thrombus surgery Petrus Järvinen (FIN)

Nurses Program10:00 - 11:00 Outpatient treatment Moderator: Herdís Sveinsdottir (ISL)The time before surgery is valuable time Eyrún Harpa Hlynsdóttir (ISL)Patient education before cystectomy Berit Kiesbye (DAN)Experiences of keeping up the results in fast-trackErica Annelise Grainger (DAN)

11:00 - 11:10 Stretching

Thursday June 6 WI-FI access is available at Harpa Nuf19 | No password required

8


SILFURBERG B KALDALÓN RÍMA A11:30 - 12:45

Stone diseaseModerators: Line Vigrestad (NOR) & Arto Mikkola (FIN)

Trends in endourologyMarianne Brehmer (SWE)

Management of stone disease in Scandinavia. A survey by the SNUG-groupKim Hovgaard Andreassen (DAN)

Immediate and long-term complications of urolithiasis treatment and how to reduce the riskHelene Jung (DAN)

Ureteric stricture formation following URSÖyvind Ulvik (NOR)

Urothelial cancerModerators: Riikka Jarvinen (FIN) & Gitte Wrist Lam (DAN)

Nordic position on HaematuriaPer-Uno Malmström (SWE)

Variant histology for bladder cancerErik Haug (NOR)

Current status for immunotherapy for bladder cancerLine Hammer Dohn (DAN)

11:10 - 12:30 Nurses ProgramProstate cancer; Quality registration of surgical complications after RALPKristín Alexíusardóttir (ISL)

A man, his spouse and the malignancy. The experience of spouses of men treated with hormonal therapy for advanced prostate cancerKristín J. Þorbergsdóttir (ISL)

NO1-01 Nurse-based elective replacement of suprapubic catheters - a survey of practice at the urologic outpatient clinic at HUS in 2014Tone Hestad Storebro (NOR)

NO1-02 Nursing care for patient fitted with a pigtail nephrostomyBeritt Bach Pedersen (DAN)

12:45 - 13:30 - LunchSponsored Satellite Symposium by Janssen - Hall Kaldalón

13:30 - 15:00

Oral Session 1 BenignModerators: Peter Östergren (DAN) & Henriette Veiby Holm (NOR)

O1-01 The morbidity associated with a TURP procedure in routine clinical practice as graded by the modified Clavien-Dindo systemErik Sagen (SWE)

Oral Session 2 Prostate CancerModerators: Erik Haug (NOR) & Helena Bertilsson (NOR)

O2-01 Determinants for choosing and adhering to active surveillance for localized prostate cancer: a nationwide population-based studyOskar Bergengren (SWE)

Nurses ProgramInpatient treatmentModerators: Bryndís Ólafsdóttir (ISL) & Kristín Björnsdóttir (ISL)

13:30 - 15:00Experiences of patients having urological surgery at Landspitali University Hospital during hospital stay, six weeks and six months laterHerdís Sveinsdóttir (ISL)

9


O1-02 Scheduling Appointments For Post Vasectomy Specimen Checks Has No Impact On Compliance Christian F S Jensen (DAN)

O1-03 Should we continue to use retrograde transurethral Ureteroscopy for impacted upper Ureteric stone? Chetan Rajendra Kulkarni (IND)

O1-04 Can Do-It-yourself (DIY) Qmean identify the obstructed male patient? Lasse Larsen Nonboe (DAN)

O1-05 A prospective study of Rezum (Water Vapor Thermal Therapy) for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia. Rimas Bliucukis (DAN)

O1-06 Five years follow-up after adult urethroplasty surgery in denmark 2014-2018. outcome and complications. Mia Børmose Trip (DAN)

O1-07 Safety and effect of low-energy extracorporeal shockwave therapy (ESWT) on the renal allograft in transplant recipients - preliminary results. Lars Lund (DAN)

O2-02 Radiotherapy with or without short term androgen deprivation therapy in intermediate risk prostate cancer: final results of a phase III randomized trial Abdenour Nabid (CAN)

O2-03 Real-time versus cognitive fusion MRI-guided prostate biopsy. Grzegorz Lukasz Fojecki (DAN)

O2-04 Preclinical study evaluating intraprostatic ethanol injection via microporous needle as a potential treatment of organ confined prostate cancer. Peter Zvara (DAN)

O2-05 Multiparametric prostate MRI in biopsy naïve men; then what? Brage Krüger-Stokke (NOR)

O2-06 Decreased mortality in men with locally advanced prostate cancer. Nationwide, population-based study in Sweden Andri Wilberg Orrason (SWE)

O2-07 The adjustable trans obturator male sling (ATOMS) for the treatment of stress urinary incontinence: Initial experience in a complex patient group Andre Westenberg (NZ)

Patient’s QoL after open kidney surgery in a randomized study of spinal versus epidural analgesia in patients with renal cell carcinoma Britt-Inger Kroger Dahlin (SWE)

Bladder pain syndrome - a retrospective cross-sectional survey of a hospital population (2010-2018) with focus on demographic characteristics and intravesical treatment modalities Kristina Førde (NOR)

Bladder pain syndrome / Chronic care model Jannike Mohn (NOR)


10


O1-08 Risks of complications after hydrocele surgery: A retrospective study in Helsinki Metropolitan Area hospitals Lauri Kalevi Mäki-Lohiluoma (FIN)

O1-09 Extra-anatomic Detour® stent in treatment of complex ureteral obstruction: a multicenter experience from three European countries Marcin Popiolek (SWE)

O1-10 Treatment of male incontinence with sling surgery in HUCH(Helsinki University Central Hospital) Kurt Daniel Grönroos (FIN)

O1-11 An initial report of a prospective study of embolization for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Kristian Als Nielsen (DAN)

O1-12 Significant impact noise of prostate biopsy device Otto Jooseppi Hemminki (FIN)

O2-08 Simulation of Prostate Cancer Incidence; Population-based study Marcus Westerberg (SWE)

O2-09 Intralesional steroid injection combined with bladder neck incision is efficacious in the treatment of recurrent bladder neck stenosis following radical prostatectomy Andre Westenberg (NZ)

O2-10 Radiation-Induced Cystitis treated with Hyperbaric Oxygen - Results from a Randomized controlled Trial (RICH-ART) Karin Margrethe Hjelle (NOR)

O2-11 Thirty-year nationwide population-based follow-up of men on active surveillance for prostate cancer: who benefits the most? A state-transition analysis Eugenio Ventimiglia (SWE)

O2-12 PSA-testing as a part of mandated health check-ups and risk of prostate cancer: Nationwide, population-based case control study of firefighters Walter Cazzaniga (IT)

O2-13 The expression of genes controlling citrate and spermine secretion is lost in aggressive prostate cancer and metastasis Morten Rye (NOR)


11

13:30 - 15:00

O1-13 Expression of renal tubular transport proteins in urinary extracellular vesicles does not correlate with their abundance in human kidney Louise Geertsen (DAN)

O1-14 Case Report: How to handle the candle Lars Anders Andreasson (SWE)

O2-14 Long-term follow up after radical prostatectomy - results from the Göteborg screening trial Rebecka Arnsrud Godtman (SWE)

O2-15 Transperineal free-hand MRI-TRUS fusion guided prostate biopsies under local anesthesia in outpatient clinic Eduard Baco (NOR)


Congress ExcursionsGolden Circle at 15:00 – 23:00 / Buses leave from Harpa

Blue Lagoon at 15:00 – 17:00 / Buses leave from Harpa

Whale Watching at 15:00 – 18:00 / The Boat leaves from Harpa

SILFURBERG B KALDALÓN RÍMA A

12

Friday June 7 WI-FI access is available at Harpa Nuf19 | No password required

SILFURBERG B08:00 - 10:00 Joint session - Urothelial cancer / Renal cancer

Moderators: Gitte Wrist Lam (DAN) & Pernilla Sundquist (SWE)

08:00 - 08:30

Conservative Management of upper urinary tract tumors - and when to stop!Fredrik Liedberg (SWE)

08:30 - 09:00

Modern treatment of non-muscle invasive bladder cancerGígja Guðbrandsdóttir (ISL)

09:00 - 09:20

Treatment of renal cell carcinoma in the elderlyLars Lund (DAN)

09:20 - 09:40

Cytoreductive and palliative renal surgeryChristian Beisland (NOR)

09:40 - 10:00

How to manage renal cysts?Harry Nisen (FIN)

10:00 - 10:30 Coffee break & Posters P17 - P29 and NP30 - 31

10:30 - 12:00 Joint session - NUF & EAU

Moderator: Rafn Hilmarsson (ISL)Anatomical Pitfalls of the Abdomen and PelvisUlf Håkanson (SWE)MRI Prior to Prostate Biopsy - A 15-Year JourneyCaroline Moore (GBR)

12:00 - 13:00 Lunch + NUF Presidium, Hall Visa

13



AndrologyModerator: Christian Fuglesang Jensen (DAN)

Testosterone deficiency and its long term consequences in subfertile men and young male cancer survivorsAlexander Giwercman (SWE)

Indications for androgen replacement therapyStefan Arver (SWE)

Complications in Reconstructive UrologyThe patient with a urological implant: Problem recognition, trouble shooting and management (acute and long term)Moderators: Ole Jacob Nilsen (NOR) & Ralph Peeker (SWE)

Speakers:Ýr Logadóttir (ISL)Teresa Ekerhult (SWE)

Iatrogenic Ureteric and Bladder Injuries after Pelvic Surgery: Presentation, diagnosis and management.Moderators: Gígja Guðbrandsdóttir (ISL) & Hans Jørgen Kirkeby (DAN)

Speakers:Yazan Rawashdeh (DAN) Bjarte Almås (NOR)

Nurses Program13:00 - 13:50 Urological variationsModerators: Rikke Nygaard Knudsen & Erica Annelise Grainger (DAN)

Psychological well-being after diagnosis and treatment for localized prostate cancer - Support throughout the cancer journeyÞórdís Katrín Þorsteinsdóttir (ISL)

The role of urological nurse in flexible photodynamic diagnosis with hexvix and diode laser ablation of bladder cancerTherese Langfeldt-Rugelbak (NOR)

13:50 - 14:00 Stretching14:00 - 15:00

Tips and tricks of penoscrotal surgeryModerator: Eiríkur Orri Guðmundsson (ISL)

Anatomy of the penoscrotal region. Surgical management of benign disorders of the scrotum, testicles and penisUlf Håkansson (SWE)

Prostate CancerModerator: Klaus Brasso (DAN) Overview of SPCG studies14:00 Introduction SPCG Research GrantSPCG´s New Chairman Klaus Brasso

14:10 Update of SPCG studiesSPCG 04 Anna Bill AxelsonSPCG 12 Ásgerður SverrisdottirSPCG 13 Andreas JosefssonSPCG 14 Andreas JosefssonSPCG 15 Olof Akre / Johan StranneSPCG 17 Anna Bill Axelson

Pelvic floor muscle training, is it all about strength?Halldóra Eyjólfsdóttir (ISL)

Multidrug resistant organismÁsdís Elvarsdóttir Jelle (ISL)

Urostoma - difficult caseOddfríður Ragnheiður Jónsdóttir (ISL)

15:00 - 15:30 Coffee

14


Oral Session 3 Urothelial CancerModerators: Riikka Jarvinen (FIN) & Gitte Wrist Lam (DAN)

O3-01 Molecular subtype classification and outcome in invasive bladder cancer treated with radical cystectomyPetter Kollberg (SWE)

O3-02 UBC@ Rapid Test - An Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-StudyThorsten Holger Ecke (DE)

O3-03 Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care in Sweden: a nationwide population-based studyFredrik Liedberg (SWE)

O3-04 The risk of perioperative complications after radical nephroureterectomy for upper tract urothelial carcinoma is acceptable even among older and comorbid patients.Bjarte Almås (NOR)

O3-05 MRI is potentially useful in the preoperative staging of upper tract urothelial carcinoma (UTUC) - results from a pilot study.Bjarte Almås (NOR)

Oral Session 4 Renal CancerModerators: Rebecka Arnsrud Godtman (SWE) & Pernilla Sundquist (SWE)

O4-01 Burden of renal cancer in Nordic countriesSara Haunstrup Næraa (DAN)

O4-02 A Prospective Study of the Implementation of Laparoscopic and Robotic Nephrectomy in Denmark in the period from 2005 to 2015Lars Lund (DAN)

O4-03 Long-term survival of patients treated with cryoablation for small renal tumoursPeter Fisker Vedel (DAN)

O4-04 Level of distress is closely related to personality and choice of coping in patients with renal tumors prior to radical surgeryElisabeth Beisland (NOR)

O4-05 Personality and choice of coping are important for self-reported health-related quality of life in patients with renal tumors prior to radical surgeryElisabeth Beisland (NOR)

O4-06 Mixed Epithelial and Stromal tumor (MEST) in the kidney - a case report of a patient with bilateral multifocal renal massesRasmus Jakobsson (SWE)


15


O3-06 CT has limited precision in the preoperative staging of upper tract urothelial carcinoma. Results from a Norwegian multicentre study.Bjarte Almås (NOR)

O3-07 Lymphadenectomy for urothelial carcinoma of the Ureter and Renal Pelvis (LURP-study)Ymir Reyr Saemundsson (SWE)

O3-08 Robot-assisted nephroureterectomy for upper tract urothelial cancer (UTUC) - a single centre experienceAnne Sörenby (SWE)

O3-09 Early versus delayed FDG-PET/CT imaging regarding detection of lymph node metastasis in patients with invasive bladder cancer scheduled for radical cystectomy - Preliminary resultsErik Hansen (DAN)

O3-10 Surgical treatment in patients with upper tract urothelial carcinoma in Iceland: A population-based studyOddur Björnsson (ISL)

O4-07 Low-volume hospitals (LVH) utilize minimally invasive radical nephrectomy less frequently than high-volume hospitals (HVH) - Results from a Norwegian population based study on surgical treatment for Renal Cell Carcinoma (RCC) >7 cm.Gigja Gudbrandsdottir (NOR)

O4-08 Bilateral Multifocal Clear cell papillary renal cell carcinoma with discordant histopathology.Rasmus Jakobsson (SWE)

O4-09 Risk of cancer recurrence seems to impact self-reported Health-related Quality of Life (HRQoL) and levels of Distress during follow-up (FU) especially in patients with neuroticismChristian Beisland (NOR)

O4-10 Local recurrence after nephron-sparing therapy in Sweden, a register based studyBörje Ljungberg (SWE)

16:30 - 17:30 NUF General Assembly19:00 - 01:00 Congress Dinner at “Gamla Bíó” the old cinema. Three course dinner

with wine and entertainment / ISK 16.200.


16

Saturday June 8 WI-FI access is available at Harpa Nuf19 | No password required

SILFURBERG B09:00 - 10:00 Complications in Urology

Acute complications after scrotal surgery: Reintervention – why, how, when and by whom?Moderators: Lotte Sander (DAN)

Speakers:Lauri Mäkilouhiluoma (FIN)Jon Örn Fridriksson (ISL)

Severe, acute complications after radical prostatectomy: This is what you need to know!Moderators: Ralph Peeker (SWE) & Lotta Renström Koskela (SWE)

Speaker:Theresa Ekerhult (SWE)

10:30 - 11:30

Prize session - Presentation of 6 best Oral abstractsModerators: Fredrik Liedberg (SWE) & Lisbeth Salling (DAN)

11:30 - 12:00

Awards and Closing RemarksChristian Beisland (NOR)Sigurður Guðjónsson (ISL)

17

P-01 Transperineal template-guided biopsies of prostate with MRI-ultrasound fusion using a modified technique with equipment for ultrasound guided radiotherapy including the advantages of a second radiologist reporting systemThorsten Holger Ecke (DE)

P-02 Subtype 16 dominates Human Papilloma Virus detection in 163 penile cancer penectomy specimen in a national study from DenmarkJakob Kristian Jakobsen (DAN)

P-03 Cutaneous metastases in renal cell carcinoma: a systematic review and a case report.Louise Geertsen (DAN)

P-04 Primary Urinary Bladder Lymphoma: a rare disease with unusual presentation.Chetan Rajendra Kulkarni (IND)

P-06 Patient affected with rare Von Hippel Lindau syndromeChetan Rajendra Kulkarni (IND)

P-07 Prospective evaluation of UBC@ Rapid and cytology in urine in patients with non-muscle invasive bladder cancer (NMIBC) - a preliminary analysis.Tammer Hemdan (SWE)

P-08 Prostate Histoscanning underperform to detect clinically significant prostate cancer in patients undergoing transperineal template mapping prostate biopsyAndrius Preidis (LTH)

P-09 Urosymphyseal fistula and osteitis pubis after external beam radiation - how to avoid and how to treat?Johan Brändstedt (SWE)

P-10 Chronic rat model for testing new therapies for stress urinary incontinecePeter Zvara (DAN)

P-11 Combining the Charlson comorbidity index with prescription data improves prediction of life expectancy in older menDavid Robinsson (SWE)

P-12 Isolation of prostate cancer-specific circulating tumor cells for androgen receptor splice variant 7 analysis: AdnaTest ProstateCancer versus Gilupi CellCollectorKlara Kvorning Ternov (DAN)

P-13 Effects of 12 weeks of supervised endurance and strength training on muscle strength, physical fitness and body composition in prostate cancer patients undergoing Androgen Deprivation Therapy. Lotte Sander (DAN)

P-14 What is the outcome after initial or delayed cystectomy for high-risk non-muscle invasive bladder cancer? A Swedish Nationwide analysis.Eugen Yu-Hui Wang (SWE)

P-15 Androgen Deprivation Treatment (ADT) in the contemporary management of prostate cancer: real life practice patterns vs. guidelinesPeter Myrenfors (SWE)

P-16 Blood transfusions during neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer may have a negative impact on overall survival.Robert Rosenblatt (SWE)

Thursday June 6 | POSTERS 09:30 – 10:00 WI-FI access is available at Harpa Nuf19 | No password required

18

Friday June 7 | POSTERS 10:00 – 10:30 WI-FI access is available at Harpa Nuf19 | No password required

P-17 Preexisting diabetes, metformin use, and long-term survival in patients with prostate cancerMarius Kincius (LTH)

P-18 Use of Tromboprophylaxis in Renal Surgery in the Nordic CountriesTorben Brøchner Pedersen (DAN)

P-19 48H-Pad Weight Test Correlation With Validated Patient Satisfaction Questionnaires after Artificial Urinary Sphincter (AUS) Implantation: The Karolinska ExperienceChristine Reus (SWE)

P-20 Patient satisfaction with Sacral Nerve Stimulation for urinary disorders.Grzegorz Lukasz Fojecki (DAN)

P-21 The significance of extended lymph node dissection to progression and death in prostate cancer after radical prostatectomyMehbod Mansoori (SWE)

P-22 Treatment algorithms for scrotal pain can be a useful tool in daily clinic.Sabrina Toft Hansen (DAN)

P-23 Multicenter study of Laparoscopic 3D prostatectomies in 3 central hospitals (Seinäjoki,Pori and Kokkola) in Finland.Henry Villehard Haapiainen (FIN)

P-24 3D laparoscopic prostatectomy: a prospective single-surgeon learning curve in first 200 cases with oncologic and functional results.Henry Villehard Haapiainen (FIN)

P-25 Improved prostate cancer diagnostics with a structured pathway including the Stockholm3 test and MRI-targeted biopsies led by nursesAndreas Thorstenson (SWE)

P-26 Association of Family History and Prostate CancerShanmugasigamani Kannan (UK)

P-27 Diagnosis of bladder cancer on patients on anticoagulantsShanmugasigamani KannanUrologist, Bangor, United Kingdom

P-28 Retrograde or antegrade stenting to treat the obstructive uropathy due to pelvic cancerAshok Kumar Kailasa (UK)

P-29 Negative ureteroscopy following emergency ureteric stentingAshok Kumar Kailasa (UK)

NP-30 Patients´ experiences of Flexible Fluorescence Cystoscopy in local anesthesia: Preliminary descriptive studyBritt Nortvig Poulsen (DAN)

NP-31 Emotional support for patient with bladder cancer undergoing blue-light flexible cystoscopy; a significant role for the urology nurseBritt Nortvig Poulsen (DAN)

THE 32ND

NUF CONGRESSJUNE 5. – 8, 2019 | REYKJAVIK, ICELAND

THE ORGANIZING COMMITTEE GRATEFULLY ACKNOWLEDGES THE VALUABLESUPPORT FROM THE FOLLOWING SPNOSORS & EXHIBITORS

GOLD SPONSOR

EXHIBITORS

Astellas Läkemedel AB

Besins Healthcare Nordics AB

BD / BARD

Boston Scientific Nordic AB

Chundsell Medical

Coloplast Danmark A/S

EDAP TMS / KOELIS

Ferring Läkemedel AB

IBSA Nordic ApS

Intuitive

Institut Produits Synthese / IPSEN AB

Janssen

Medac

MEQnordic

Olympus

Photocure

Pierre Fabre Pharma N. AB

Prosta Lund

Sobi

Teleflex

SILVER SPONSOR

the 32nd nuf congress · o1-04 can do-it-yourself (diy) qmean identify the obstructed male patient?...

Documents